Literature DB >> 8881509

Insulin-like growth factor-1 and myocyte growth: the danger of a dogma part II. Induced myocardial growth: pathologic hypertrophy.

P Anversa1, J Kajstura, W Cheng, K Reiss, E Cigola, G Olivetti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8881509

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN： 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  4 in total

Review 1.  Contemporary perspective on endogenous myocardial regeneration.

Authors:  Dejan Milasinovic; Werner Mohl
Journal:  World J Stem Cells       Date:  2015-06-26       Impact factor: 5.326

2.  Body mass index, treatment practices, and mortality in patients with acute heart failure.

Authors:  Timothy P Fitzgibbons; Olga T Hardy; Darleen Lessard; Joel M Gore; Jorge Yarzebski; Robert J Goldberg
Journal:  Coron Artery Dis       Date:  2009-12       Impact factor: 1.439

Review 3.  Apoptosis and oncosis in acute coronary syndromes: assessment and implications.

Authors:  Bodh I Jugdutt; Halliday A Idikio
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

4.  Cardiac ISL1-Interacting Protein, a Cardioprotective Factor, Inhibits the Transition From Cardiac Hypertrophy to Heart Failure.

Authors:  Youchen Yan; Tianxin Long; Qiao Su; Yi Wang; Ken Chen; Tiqun Yang; Guangyin Zhao; Qing Ma; Xiaoyun Hu; Chen Liu; Xinxue Liao; Wang Min; Shujuan Li; Dihua Zhang; Yuedong Yang; William T Pu; Yugang Dong; Da-Zhi Wang; Yili Chen; Zhan-Peng Huang
Journal:  Front Cardiovasc Med       Date:  2022-03-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.